Review Article
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
Table 1
Comparison of AUC and in various tissues in dogs following the administration of TLC D-99 and conventional doxorubicin. Single dose 1.5 mg/kg (30 mg · m−2), IV [18].
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Due to short sampling intervals relating to apparent , these values are estimated. TLC D-99: nonpegylated liposomal doxorubicin. |